| Detection of Huntington’s disease decades before diagnosis: the Predict-HD study JS Paulsen, DR Langbehn, JC Stout, E Aylward, CA Ross, M Nance, ... Journal of Neurology, Neurosurgery & Psychiatry 79 (8), 874-880, 2008 | 972 | 2008 |
| Levodopa in the treatment of Parkinson's disease: Current controversies (vol 19, pg 997, 2004) CW Olanow, Y Agid, Y Mizuno, A Albanese, U Bonuccelli, P Damier, ... MOVEMENT DISORDERS 20 (5), 645-645, 2005 | 514* | 2005 |
| Levodopa in the treatment of Parkinson's disease: current controversies CW Olanow, Y Agid, Y Mizuno, A Albanese, U Bonucelli, P Damier, ... Movement Disorders 19 (9), 997-1005, 2004 | 514 | 2004 |
| Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease SJ Kish, J Tong, O Hornykiewicz, A Rajput, LJ Chang, M Guttman, ... Brain 131 (1), 120-131, 2008 | 456 | 2008 |
| CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ... Neurology 78 (10), 690-695, 2012 | 454 | 2012 |
| Adenosine A2A receptor antagonist istradefylline (KW‐6002) reduces “off” time in Parkinson's disease: A double‐blind, randomized, multicenter clinical trial (6002‐US‐005) PA LeWitt, M Guttman, JW Tetrud, PJ Tuite, A Mori, P Chaikin, ... Annals of neurology 63 (3), 295-302, 2008 | 410 | 2008 |
| Preparing for preventive clinical trials: the Predict-HD study JS Paulsen, M Hayden, JC Stout, DR Langbehn, E Aylward, CA Ross, ... Archives of neurology 63 (6), 883-890, 2006 | 396 | 2006 |
| The role of radiotracer imaging in Parkinson disease B Ravina, D Eidelberg, JE Ahlskog, RL Albin, DJ Brooks, M Carbon, ... Neurology 64 (2), 208-215, 2005 | 393 | 2005 |
| Identification of motor and nonmotor wearing‐off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment M Stacy, A Bowron, M Guttman, R Hauser, K Hughes, JP Larsen, P LeWitt, ... Movement disorders 20 (6), 726-733, 2005 | 316 | 2005 |
| Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease M Guttman, International Pramipexole-Bromocriptine Study Group Neurology 49 (4), 1060-1065, 1997 | 293 | 1997 |
| Clinical markers of early disease in persons near onset of Huntington’s disease JS Paulsen, H Zhao, JC Stout, RR Brinkman, M Guttman, CA Ross, ... Neurology 57 (4), 658-662, 2001 | 263 | 2001 |
| Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease JM Wilson, AI Levey, A Rajput, L Ang, M Guttman, K Shannak, HB Niznik, ... Neurology 47 (3), 718-726, 1996 | 255 | 1996 |
| Current concepts in the diagnosis and management of Parkinson's disease M Guttman, SJ Kish, Y Furukawa Canadian Medical Association Journal 168 (3), 293-301, 2003 | 236 | 2003 |
| Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease SA Johnson, JC Stout, AC Solomon, DR Langbehn, EH Aylward, ... Brain 130 (7), 1732-1744, 2007 | 235 | 2007 |
| Brain α-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation J Tong, H Wong, M Guttman, LC Ang, LS Forno, M Shimadzu, AH Rajput, ... Brain 133 (1), 172-188, 2010 | 231 | 2010 |
| Thalamic metabolism and symptom onset in preclinical Huntington's disease A Feigin, C Tang, Y Ma, P Mattis, D Zgaljardic, M Guttman, JS Paulsen, ... Brain 130 (11), 2858-2867, 2007 | 227 | 2007 |
| Brain serotonin transporter binding in non‐depressed patients with Parkinson's disease M Guttman, I Boileau, J Warsh, JA Saint‐Cyr, N Ginovart, T McCluskey, ... European journal of neurology 14 (5), 523-528, 2007 | 227 | 2007 |
| [11C] RTI‐32 PET studies of the dopamine transporter in early dopa‐naive Parkinson's disease Implications for the symptomatic threshold M Guttman, J Burkholder, SJ Kish, D Hussey, A Wilson, J DaSilva, ... Neurology 48 (6), 1578-1583, 1997 | 227 | 1997 |
| Cerebral glucose metabolism in Parkinson's disease with and without dementia RF Peppard, WR Martin, GD Carr, E Grochowski, M Schulzer, M Guttman, ... Archives of neurology 49 (12), 1262, 1992 | 213 | 1992 |
| Dopa decarboxylase activity of the living human brain. A Gjedde, J Reith, S Dyve, G Leger, M Guttman, M Diksic, A Evans, ... Proceedings of the National Academy of Sciences 88 (7), 2721-2725, 1991 | 203 | 1991 |
